What'sNearbyTM

What are you looking for?

Close Search
      We apologize for the inconvenience

      The people search feature on Superpages.com is temporarily unavailable. You can still search for people on yellowpages.com since Yellow Pages and Superpages are part of one company.

      You will be automatically re-directed to People Search on yellowpages.com in .

      Nicholas J. Vogelzang, MD, FASCO, FACP

      Add to Favorites
      Be the first to review!
      Physicians & Surgeons, Cancer Treatment Centers, Physicians & Surgeons, Oncology

      3730 S Eastern Ave, Las Vegas, NV 89169

      702-952-3400

      CLOSED NOW: 
      Today: 9:00 am - 5:00 pm
      Amenities:
      Wheelchair accessible
      CallWebsite

      REVIEWS write reviewWrite a Review

      Be the first to review!
      First-classBetter than mostAbout what I expectedNot the worst...Disappointing
      DETAILS
      General Info
      Dr. Vogelzang is a renowned medical oncologist and cancer researcher who has authored/coauthored numerous peer-reviewed articles, book chapters and abstracts and has given hundreds of lectures and presentations to his peers worldwide. Dr. Vogelzang joined Comprehensive Cancer Centers of Nevada (CCCN) as a medical oncologist in 2009. He serves as Medical Director for the Genitourinary Research Committee through US Oncology Research and Vice Chair of SWOG, a worldwide network of researchers that design and conduct cancer clinical trials. He is also Associate Editor of Kidney Cancer Journal and Clinical Genitourinary Cancer. Prior to joining CCCN, he served as Director of Nevada Cancer Institute from 2004 to 2009. From 1999 to 2003, Dr. Vogelzang was Professor and Director of the University of Chicago Cancer Research Center and faculty member from 1982 to 2003. Dr. Vogelzang leads cutting-edge clinical trials in genitourinary malignancies and mesothelioma and is involved in new therapies for patients with metastatic kidney, bladder and prostate cancer. He has lead research in Las Vegas for two recent FDA-approved prostate cancer treatments – Provenge and Xofigo. In 2014, Nature published his research on an anti-PD-L1 treatment called atezolizumab for metastatic bladder cancer. The FDA is likely to approve the antibody for bladder cancer in 2016.
      Extra Phones

      Phone: 702-952-3461

      Hours
      Regular Hours
      Mon - Fri:
      Categories
      Physicians & Surgeons, Cancer Treatment Centers, Physicians & Surgeons, Oncology
      Services/Products
      Comprehensive Cancer Centers of Nevada (CCCN) is the award-winning multidisciplinary oncology group comprising medical oncology, hematology, radiation oncology, breast surgery and pulmonary medicine, with 15 treatment centers and offices throughout Southern Nevada.
      Payment Options
      Amenities
      When it comes to cancer treatment and blood disorders, we know you have a choice for different treatment options. With more doctors trusting their patients to Comprehensive Cancer Centers of Nevada (CCCN) than to all other Nevada cancer treatment facilities combined, be assured that you have made the right one. At CCCN, you will have access to advanced treatments, clinical research and modern facilities where everyone, from the person who greets you to the doctor who treats you, will do everything in their power to help you get well. Since your treatment may require several different oncology medical services, CCCN’s treatment centers are equipped to identify a treatment plan that meets your individual needs.
      Other Links

      http://www.cccnevada.com/doctor/nicholas-vogelzang-md

      http://www.cccnevada.com

      Other Information

      Specialties: Hematology Oncology, Hematology, Genitourinary Malignancies (prostate, kidney, bladder and testicular cancer), Mesothelioma and Clinical Research.

      Suggest an Edit
      Data provided by one or more of the following: Thryv, Data Axle, Yext.